SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $94,000 | -34.7% | 97,135 | -19.8% | 0.00% | – |
Q1 2022 | $144,000 | -36.8% | 121,135 | +72.9% | 0.00% | – |
Q4 2021 | $228,000 | +8.1% | 70,060 | +48.7% | 0.00% | – |
Q3 2021 | $211,000 | +1.4% | 47,115 | +23.7% | 0.00% | – |
Q2 2021 | $208,000 | +43.4% | 38,090 | +97.1% | 0.00% | – |
Q1 2021 | $145,000 | -4.6% | 19,328 | +37.9% | 0.00% | – |
Q4 2020 | $152,000 | – | 14,020 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |